Secondary pulmonary tuberculosis in one patient with myelodysplastic syndrome during recovery period of Pneumocystis jirovecii pneumonia

doi:10.3760/cma.j.issn.1007-1245.2023.22.009

Abstract

Abstract:

Myelodysplastic syndrome (MDS) is characterized by abnormal hematopoiesis of blood cells. Patients with MDS often have low immune function. This paper reports a case of MDS patient with chest tightness as the main symptom. The patient was admitted to Weihai Central Hospital, Qingdao University and diagnosed with Pneumocystis jirovecii pneumonia. After treatment, the conditions were improved. However, the patient was hospitalized again because of fever, and the application of conventional anti-infective drugs was ineffective. After the second-generation sequencing technology, the patient was finally diagnosed as pulmonary tuberculosis. The related literatures were reviewed in order to provide some help to clinical work.

Key words:

Myelodysplastic syndrome, Pneumocystis jirovecii pneumonia, Pulmonary tuberculosis, Next-generation sequencing

摘要：

骨髓增生异常综合征（MDS）以血细胞病态造血为特点，患者常存在免疫功能低下。本文报道的1例MDS患者以胸闷憋气为主要症状就诊于青岛大学附属威海市中心医院，确诊为耶氏肺孢子菌肺炎，经治疗病情好转。后因发热再次就诊，常规抗感染无效，经二代测序技术最终诊断为肺结核。并复习相关文献，以期对临床工作提供帮助。

关键词:

骨髓增生异常综合征, 耶氏肺孢子菌肺炎, 肺结核, 二代测序技术

Li Fei, Guo Lijuan, Shi Xinjie.

Secondary pulmonary tuberculosis in one patient with myelodysplastic syndrome during recovery period of Pneumocystis jirovecii pneumonia [J]. International Medicine and Health Guidance News, 2023, 29(22): 3187-3190.

李飞郭丽娟时新杰.

骨髓增生异常综合征患者耶氏肺孢子菌肺炎恢复期继发肺结核1例 [J]. 国际医药卫生导报, 2023, 29(22): 3187-3190.

References

[1] 刘娟,王东江,王京华.骨髓增生异常综合征患者骨髓涂片的免疫表型分析[J].国际免疫学杂志,2010,33(5):415-416,封3.DOI:10.3760/cma.j.issn.1673-4394.2010.05.021.
[2] Wang C, Yang Y, Gao S, et al. Immune dysregulation in myelodysplastic syndrome: clinical features, pathogenesis and therapeutic strategies[J]. Crit Rev Oncol Hematol, 2018,122:123-132. DOI: 10.1016/j.critrevonc.2017. 12.013.
[3] 庞艳彬,田方园,史雅楠,等.骨髓增生异常综合征中的T细胞免疫[J].国际免疫学杂志,2017,40(5):584-588.DOI:10.3760/cma.j.issn.1673-4394.2017.05.025.
[4] Matos A, Magalhães SMM, Rauh MJ. Immune dysregulation and recurring mutations in myelodysplastic syndromes pathogenesis[J]. Adv Exp Med Biol, 2021,1326:1-10. DOI: 10.1007/5584_2020_608.
[5] Hochman MJ, DeZern AE. Myelodysplastic syndrome and autoimmune disorders: two sides of the same coin?[J]. Lancet Haematol, 2022,9(7):e523-e534. DOI: 10.1016/S2352-3026(22)00138-7.
[6] Barcellini W, Fattizzo B. Immune phenomena in myeloid neoplasms: an "Egg or Chicken" question[J]. Front Immunol, 2021,12:751630. DOI: 10.3389/fimmu. 2021.751630.
[7] Bienvenu AL, Traore K, Plekhanova I, et al. Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients[J]. Int J Infect Dis, 2016,46:11-17. DOI: 10.1016/j.ijid.2016.03.018.
[8] Nasr M, Mohammad A, Hor M, et al. Exploring the differences in pneumocystis pneumonia infection between HIV and non-HIV patients[J]. Cureus, 2022,14(8):e27727. DOI: 10.7759/cureus.27727.
[9] Catherinot E, Lanternier F, Bougnoux ME, et al. Pneumocystis jirovecii pneumonia[J]. Infect Dis Clin North Am, 2010,24(1):107-138. DOI: 10.1016/j.idc.2009.10.010.
[10] Ghembaza A, Vautier M, Cacoub P, et al. Risk factors and prevention of pneumocystis jirovecii pneumonia in patients with autoimmune and inflammatory diseases[J]. Chest, 2020,158(6):2323-2332. DOI: 10.1016/j.chest.2020.05.558.
[11] Malpica L, van Duin D, Moll S. Preventing infectious complications when treating non-malignant immune-mediated hematologic disorders[J]. Am J Hematol, 2019,94(12):1396-1412. DOI: 10.1002/ajh.25642.
[12] Zeng G, Zhang G, Chen X. Th1 cytokines, true functional signatures for protective immunity against TB?[J]. Cell Mol Immunol, 2018,15(3):206-215. DOI: 10.1038/cmi.2017.113.
[13] 刘玉坤,郭智.慢性髓系白血病与结核病共病研究进展[J].结核与肺部疾病杂志,2022,3(4):325-327.DOI:10.19983/j.issn.2096-8493.20220108.
[14] 孙勤,张青.免疫功能低下患者并发肺结核影像特征分析——附240例报告[J].海南医学,2010,21(7):29-31.DOI:10.3969/j.issn.1003-6350.2010.07.012.
[15] 伍建林,施裕新,刘晋新,等.免疫抑制宿主肺结核影像学表现及发病机制[J].中国医学计算机成像杂志,2010,16(5):415-419.DOI:10.3969/j.issn.1006-5741.2010.05.012.
[16] 王钰琪,任靖宜,康小文.二代测序技术在结核病病原学诊断、耐药性检测及流行病学监测中的应用研究进展[J].山东医药,2022,62(5):110-113.DOI:10.3969/j.issn.1002- 266X.2022.05.028.